The DOI matches its Crossref record; 67 of the 74 references it cites were found in a registry or an index.
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abstract
Zolmitriptan (ZT) is a well-tolerated drug in migraine treatment suffering from low bioavailability due to low amount of the drug that reaches the brain after oral and nasal delivery. Development of new nasal mucoadhesive nanoemulsion formulation for zolmitriptan may success in delivering the drug directly from the nose to the brain to achieve rapid onset of action and high drug concentration in the brain which is required for treatment of acute migraine. ZT mucoadhesive nanoemulsion were prepared and characterized for drug content, zeta potential, particle size, morphology, residence time and permeation through the nasal mucosa. The selected formula was tested in-vivo in mice for its pharmacokinetics in comparison with intravenous and nasal solution of zolmitriptan. Results showed that addition of chitosan as mucoadhesive agent in 0.3% concentration to the nanoemulsion enhanced its residence time and zetapotential with no significant effect on the globule size. All tested formulations showed higher permeability coefficients than the zolmitriptan solution through the nasal mucosa. In-vivo studies showed that the mucoadhesive nanoemulsion formulation of zolmitriptan has higher AUC 0-8 and shorter T max in the brain than the intravenous or the nasal solution. This was related to the small globule size and higher permeability of the formulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Important differences can be found between classical macroemulsions (classical emulsions), NEs and microemulsions in droplet size range and stability characteristics [32,47].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
In the citing paper
“In vivo studies carried out on Sprague–Dawley rats showed that the mucoadhesive (chitosan containing) NE presents higher AUC and shorter Tmax in the brain than intravenous or the nasal solutions.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
In the citing paper
“The addition to the NE of chitosan as a mucoadhesive agent in 0.3% enhanced the residence time and zeta potential of the formulation with no relevant effect on the globule size.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [47]
Citations
Cites
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 432
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 307
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K. S., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Research works printed but not linked: 6
- Awari, 2013, Bio analytical hplc method development and validation of zolmitriptan in rabbit plasma, Int. J. Bio. Pharm. Res., 4, 1160
- Kolsure, 2012, Development of zolmitriptan gel for nasal administration, Asian J. Pharm. Clin. Res., 5, 88
- Meor Mohd Affandi, 2011, Development and stability evaluation of Astaxanthin nanoemulsion, Asian J. Pharm. Clin. Res., 4, 142
- Niranjan, 2015, Formulation, design and in vitro evaluation of zolmitriptan immediate release tablets using Primojel and AC-Di-Sol, J. Pharm. Sci. Res., 7, 545
- Patel, 2013, Formulation and evaluation of microemulsion based-drug delivery system for intranasal administration of olanzapine, Int. J. Biomed. Pharm. Sci., 7, 20
- Tandel, 2015, Preparation and study of efavirenz microemulsion drug delivery system for enhancement of bioavailability, Euro. J. Pharm. Med. Res., 2, 1156
Cited by
Sorted by citations
Nanoemulsions for drug delivery
Wilson, R. J., Li, Y., Yang, G., & Zhao, C. (2021) · Particuology · doi:10.1016/j.partic.2021.05.009 · Cited by 410
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Jeong, S., Jang, J.-H., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 289
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
Mura, P., Maestrelli, F., Cirri, M., & Mennini, N. (2022) · Marine Drugs · doi:10.3390/md20050335 · Cited by 279
Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 247
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 223
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C. P., Moreira, J. N., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 216
Nanoemulsions in Drug Delivery: Formulation to Medical Application
Tayeb, H. H., & Sainsbury, F. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0088 · Cited by 190
A critical review of synthesis procedures, applications and future potential of nanoemulsions
Naseema, A., Kovooru, L., Behera, A. K., Kumar, K. P. P., & Srivastava, P. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102318 · Cited by 186
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders
Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 193
Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System
Ojeda-Hernández, D. D., Canales-Aguirre, A. A., Matías‐Guiu, J., Gómez‐Pinedo, U., & Mateos‐Díaz, J. C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00389 · Cited by 175
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 178
Recent expansions of novel strategies towards the drug targeting into the brain
Alexander, A., Agrawal, M., Uddin, A. N. M. S., Siddique, S., Shehata, A. M., Shaker, M. A., Rahman, S. A. U., Abdul, M. I. M., & Shaker, M. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210876 · Cited by 165
Recent progress in nanocarriers for direct nose to brain drug delivery
Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 114
Lofts, A., Abu-Hijleh, F. A., Rigg, N., Mishra, R. K., & Hoare, T. R. (2022) · CNS Drugs · doi:10.1007/s40263-022-00930-4 · Cited by 118
Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines
Ewii, U. E., Attama, A. A., Olorunsola, E. O., Onugwu, A. L., Nwakpa, F. U., Anyiam, C. K., Chijioke, C., & Ogbulie, T. E. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100083 · Cited by 121
Microemulsion-Based Media in Nose-to-Brain Drug Delivery
Froelich, A., Osmałek, T. Z., Jadach, B., Puri, V., & Michniak‐Kohn, B. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020201 · Cited by 110
Chitosan-Based Nanocarriers for Nose to Brain Delivery
Aderibigbe, B. A., & Naki, T. (2019) · Applied Sciences · doi:10.3390/app9112219 · Cited by 105
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
Karami, Z., Zanjani, M. R. S., & Hamidi, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.021 · Cited by 102
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Medicines · doi:10.3390/medicines6010007 · Cited by 96
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery
Alshweiat, A., Ambrus, R., & Csóka, I. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190827151741 · Cited by 85
Gul, U., Khan, M. I., Madni, A., Sohail, M. F., Rehman, M., Rasul, A., & Peltonen, L. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2039805 · Cited by 85
Kumbhar, S. A., Kokare, C., Shrivastava, B., Gorain, B., & Choudhury, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119499 · Cited by 80
Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel
Wang, J. T.-W., Rodrigo, A. C., Patterson, A. K., Hawkins, K., Aly, M. M. S., Sun, J., Al‐Jamal, K. T., & Smith, D. K. (2021) · Advanced Science · doi:10.1002/advs.202101058 · Cited by 75
Patharapankal, E. J., Ajiboye, A. L., Mattern, C., & Trivedi, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010066 · Cited by 75
Sintov, A. C. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119725 · Cited by 67
Pardeshi, C. V., & Belgamwar, V. S. (2019) · Materials Technology · doi:10.1080/10667857.2019.1674522 · Cited by 61
Pardeshi, C. V., & Belgamwar, V. S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.032 · Cited by 60
Microemulsion as drug and gene delivery vehicle: an inside story
Rajpoot, K., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00010-7 · Cited by 56
Yan, X., Long, Y., Yang, Q., Zheng, C., Cui, M., Ci, Z., Lv, X.-M., Li, N., & Zhang, R. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146503 · Cited by 57
Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide
Bayanati, M., Khosroshahi, A. G., Alvandi, M., & Mahboobian, M. M. (2021) · Journal of Nanomaterials · doi:10.1155/2021/1546798 · Cited by 57
Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence
Misra, S. K., & Pathak, K. (2023) · Colloids and Interfaces · doi:10.3390/colloids7010023 · Cited by 53
Direct nose to the brain nanomedicine delivery presents a formidable challenge
Yokel, R. A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1767 · Cited by 53
Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 50
Yadav, S., Singh, A., Palei, N. N., Pathak, P., Verma, A., & Yadav, J. P. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02948-x · Cited by 48
Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging
Thangam, R., Paulmurugan, R., & Kang, H. (2021) · Nanomaterials · doi:10.3390/nano12010018 · Cited by 45
Application of diethylene glycol monoethyl ether in solubilization of poorly water-soluble drugs
Ha, E., Lee, S.-K., Choi, D. H., Jeong, S. H., Hwang, S., & Kim, M. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00454-y · Cited by 42
Xue, F., Li, X., Qin, L., Liu, X., Li, C., & Adhikari, B. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113886 · Cited by 45
Bahadur, S., & Jha, M. K. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103932 · Cited by 42
Nanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 44
El-Enin, H. A. A., Mostafa, R. E., Ahmed, M. F. E., Naguib, I. A., Abdelgawad, M. A., Ghoneim, M. M., & Abdou, E. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020410 · Cited by 39
Self-citationAkhter, A., Shirazi, J. H., Khan, H. M. S., Hussain, M. D., & Kazi, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35069 · Cited by 46
Sreeharsha, N., Meravanige, G., Karnati, R. K., Bakir, E. M., & Pund, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081216 · Cited by 39
Diedrich, C., Zittlau, I. C., Machado, C. S., Fin, M. T., Khalil, N. M., Badea, I., & Mainardes, R. M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122142 · Cited by 38
Nair, A. B., Chaudhary, S. A., Jacob, S., Patel, D., Shinu, P., Shah, H., Chaudhary, A., Al‐Dhubiab, B. E., Almuqbil, R. M., Alnaim, A., et al. (2023) · Gels · doi:10.3390/gels9020130 · Cited by 37
Nanoemulsion preparation, characterization, and application in the field of biomedicine
Chircov, C., & Grumezescu, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816200-2.00019-0 · Cited by 37
Bonaccorso, A., Ortis, A., Musumeci, T., Carbone, C., Hussain, M., Salvatore, V. D., Battiato, S., Pappalardo, F., & Pignatello, R. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s452316 · Cited by 35
Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective
Curcio, M., Cirillo, G., Rouaen, J. R. C., Saletta, F., Nicoletta, F. P., Vittorio, O., & Iemma, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121183 · Cited by 35
Al-mahallawi, A. M., Ahmed, D., Hassan, M., & El-Setouhy, D. A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102561 · Cited by 35
Application of ionic liquid to enhance the nose-to-brain delivery of etodolac
Tanigawa, H., Suzuki, N., & Suzuki, T. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106290 · Cited by 33
Alexander, A., Agrawal, M., Chougule, M. B., Saraf, S., & Saraf, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817778-5.00009-9 · Cited by 31
Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition
Gorain, B., Rajeswary, D. C., Pandey, M., Kesharwani, P., Kumbhar, S. A., & Choudhury, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200313125613 · Cited by 31
Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems
de Barros, C. T., Portugal, I., Batain, F., Portella, D. L., Severino, P. B., Cardoso, J. C., Arcuri, P., Chaud, M. V., & Alves, T. (2022) · RPS Pharmacy and Pharmacology Reports · doi:10.1093/rpsppr/rqac003 · Cited by 29
Wu, D., Salah, Y. A., Ngowi, E. E., Zhang, Y., Khattak, S., Khan, N. H., Wang, Y., Li, T., Guo, Z.-H., Wang, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107321 · Cited by 30
Patel, M. R., Patel, R. B., Thakore, S. D., & Solanki, A. B. (2020) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2020.1772292 · Cited by 28
Intranasal delivery of gabapentin loaded optimized nanoemulsion for augmented permeation
Mallick, A., Gupta, A., Hussain, A., Aparajay, P., Singh, S., Singh, S. K., & Dev, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101606 · Cited by 26
Saha, P., Kathuria, H., & Pandey, M. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104049 · Cited by 26
Huang, C.-H., Wang, C., Zhang, W., Yang, T., Xia, M., Lei, X., Peng, Y., Wu, Y., Feng, J., Li, D., et al. (2022) · Molecules · doi:10.3390/molecules27217644 · Cited by 25
Recent Update on Pharmacokinetics and Drug Metabolism in CNS-based Drug Discovery
Sanap, S. N., Bisen, A. C., Kedar, A. S., Agrawal, S., & Bhatta, R. S. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230707121415 · Cited by 26
Recent exploration of nanoemulsions for drugs and cosmeceuticals delivery
Abu‐Huwaij, R., Al‐Assaf, S. F., & Hamed, R. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14704 · Cited by 23
Exploring Nose to Brain Nano Delivery for Effective Management of Migraine
Tanna, V., Sawarkar, S. P., & Ravikumar, P. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220401091632 · Cited by 22
Nabipour, H., & Rohani, S. (2024) · Nanomaterials · doi:10.3390/nano14171379 · Cited by 22
Vitore, J. G., Bharathi, K., Salave, S., Rana, D., Perla, A., Gupta, S., Shah, S., Pardhe, R., Chittemreddy, P., Kashid, S., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104421 · Cited by 23
Optimized Chitosan-Based Nanoemulsion Improves Luteolin Release
Diedrich, C., Zittlau, I. C., Khalil, N. M., Leontowich, A. F. G., de Freitas, R. A., Badea, I., & Mainardes, R. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061592 · Cited by 22
Abdulwahab, S., Suardi, N., Dheyab, M. A., Abdullah, W., Aziz, A. A., Alanezi, S. T., Alsardi, M. M., Tarawneh, M. H., & Ghasemlou, M. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103685 · Cited by 21
Kumar, M., Nishad, D. K., Kumar, A., Bhatnagar, A., Karwasra, R., Khanna, K., Keerthana, S. V., Sharma, D., Dua, K., Mudaliar, V., et al. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1801870 · Cited by 21
Nanocarriers for effective drug delivery
Theochari, I., Xenakis, A., & Papadimitriou, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816770-0.00019-8 · Cited by 22
Abdou, E. M., Kandil, S. M., Morsy, A. R., & Sleem, M. W. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1618419 · Cited by 19
Self-citationZhu, S., Zhang, S., Pang, L., Ou, G., Zhu, L., Ma, J., Li, R., Liu, Y., Wang, L., Wang, L., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120343 · Cited by 19
ElMosbah, D. E., Khattab, M. S., Ibrahim, M. A., El-Assal, M. I. A., & Miniawy, H. M. F. E. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01541-9 · Cited by 18
Self-citationIntranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations
Muntoni, E., Marini, E., Ferraris, C., Garelli, S., Capucchio, M. T., Colombino, E., Panciani, P. P., & Battaglia, L. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112470 · Cited by 18
Santos, J. D. S., Diedrich, C., Machado, C. S., da Fonseca, C. O., Khalil, N. M., & Mainardes, R. M. (2020) · Biomedical Chromatography · doi:10.1002/bmc.5037 · Cited by 16
Kannavou, M., Karali, K., Κάτσιλα, Θ., Siapi, E., Marazioti, A., Klepetsanis, P. G., Calogeropoulou, T., Charalampopoulos, I., & Antimisiaris, S. G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020419 · Cited by 16
El‐Adl, K., Ghobashy, M. M., Ismail, A. F. M., El-morsy, A., & Shoman, N. A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03573-y · Cited by 16
Design and Fabrication of Brain-Targeted Drug Delivery
Soni, V., Pandey, V., Asati, S., Jain, P., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00014-5 · Cited by 14
Negi, M., Amulya, E., Phatale, V., Kumar, R., & Srivastava, S. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214835 · Cited by 13
Progress in research and development of temozolomide brain-targeted preparations: a review
Yang, J., Xu, Y., Fu, Z., Chen, J., Fan, W., & Wu, X. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2119243 · Cited by 14
Dogra, A., Narang, R. S., Kaur, T., & Narang, J. K. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-023-02727-0 · Cited by 12
Kassem, M. A., Ghalwash, M. M., & Abdou, E. M. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1771446 · Cited by 12
Self-citationZaki, R. M., Aldawsari, M. F., Alossaimi, M. A., Alzaid, S. F., Seshadri, V. D., Almurshedi, A. S., Aldosari, B. N., Yusif, R. M., & Sayed, O. M. (2022) · Pharmaceuticals · doi:10.3390/ph15091083 · Cited by 12
An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery
Kumar, V., Garg, V., Saini, N., Aggarwal, N., Kumar, H., Kumar, D., Chopra, H., Kamal, M. A., & Dureja, H. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010267771240211124950 · Cited by 11
Moreira, F. F., Ziebarth, J., Babinski, T. P., & Mainardes, R. M. (2025) · ACS Omega · doi:10.1021/acsomega.4c10474 · Cited by 11
Self-Assembled systems for Nose-to-Brain delivery of Temozolamide (TMZ) in brain tumor therapy
Bhagat, N., Nalawala, Z., Patel, J., Das, D., Baldha, R., Sarolia, J., & Rathod, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125540 · Cited by 9
Nose-to-brain delivery of biologics and stem cells
Agrawal, M., Konwar, A. N., Alexander, A., & Borse, V. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00015-1 · Cited by 9
Jebali, S., Belgacem, C., Louhaichi, M. R., Bahri, S., & Latrous, L. (2019) · International Journal of Analytical Chemistry · doi:10.1155/2019/9685750 · Cited by 9
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8
Youssef, N. A. H. A., Labib, G. S., Kassem, A. A., & El-Mezayen, N. S. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01731-6 · Cited by 8
Jadhav, K., Jhilta, A., Singh, R., Negi, S., Sharma, S., Shukla, R., Singh, A. K., & Verma, R. K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00767 · Cited by 7
Current Perspectives on Nanoemulsions in Targeted Drug Delivery
Zeytünlüoğlu, A., & Arslan, İ. (2021) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-7998-8378-4.ch006 · Cited by 7
Intranasal Oleic acid-based nanoemulsion of Diazepam: design, formulation and in-vitro evaluation
YOUNIS, Y. K., & Alhammid, S. N. A. (2023) · Journal of Research in Pharmacy · doi:10.29228/jrp.335 · Cited by 6
Challenges in Targeting Nasal Passage and Nose-to-Brain Delivery via Nanoemulsions
Bahadur, S., & Pathak, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_5 · Cited by 6
Intranasal delivery systems for traumatic brain injury: Advancements and perspectives
Yoo, S. H., Heo, S. C., Bae, J. S., Lee, J. H., Knowles, J. C., & Kim, H. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251372373 · Cited by 5
Progress in nasal drug delivery research based on biomaterials
Qiu, H., Duan, X., Su, Y., Zeng, S., Zheng, D., & Liao, W. (2025) · APL Materials · doi:10.1063/5.0296863 · Cited by 5
Lorenzett, A. K. P., Babinski, T. P., de Lima, V. A., & Mainardes, R. M. (2025) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.4c00057 · Cited by 5
Darooee, M., Akbari, V., & Taheri, A. (2021) · Therapeutic Delivery · doi:10.4155/tde-2020-0130 · Cited by 5
Spoorthi, R., Veerapur, V. P., Prashanthi, D., & Chaithanya, M. S. (2024) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/s7kxf2ilbp · Cited by 4
Dutta, B. J., Patil, V., Gaikwad, V. L., & Singh, S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2574384 · Cited by 3
Dogra, A., Narang, R. S., Kaur, T., Kaur, S., Dang, S., & Narang, J. K. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02798-y · Cited by 3
A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions
Shirsath, K., & Agrawal, Y. O. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220622163403 · Cited by 3
Singpanna, K., Taeranakayo, N., Wongrot, P., Kaewvisitkun, W., Opanasopit, P., Chaksmithanont, P., Pornpitchanarong, C., & Patrojanasophon, P. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106195 · Cited by 2
Metadata
- Authors
- Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E.
- Affiliations
- National Organization for Drug Control and Research (EG)
- Modern University for Information and Technology (EG)
- Cairo University (EG)
- Corresponding author
- Abdou, Ebtsam M.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 529
- Issue
- 1-2
- Pages
- 667-677
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2735486104
- Cited by
- 124
- References
- 74
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 18 · 2021: 15 · 2020: 17 · 2019: 18 · 2018: 4
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- zolmitriptan, migraine, intranasal drug delivery, chitosan, nasal mucosa permeation, brain targeting, pharmacokinetics, residence time, globule size, zeta potential, acute migraine treatment
- MeSH terms
- Administration, Intranasal, Animals, Brain, Chemistry, Pharmaceutical, Migraine Disorders, Nasal Mucosa, Tryptamines, Oxazolidinones, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review